| Year |
Citation |
Score |
| 2004 |
Carven GJ, Chitta S, Hilgert I, Rushe MM, Baggio RF, Palmer M, Arenas JE, Strominger JL, Horejsi V, Santambrogio L, Stern LJ. Monoclonal antibodies specific for the empty conformation of HLA-DR1 reveal aspects of the conformational change associated with peptide binding. The Journal of Biological Chemistry. 279: 16561-70. PMID 14757758 DOI: 10.1074/Jbc.M314315200 |
0.855 |
|
| 2002 |
Ge Q, Stone JD, Thompson MT, Cochran JR, Rushe M, Eisen HN, Chen J, Stern LJ. Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC molecules. Proceedings of the National Academy of Sciences of the United States of America. 99: 13729-34. PMID 12374859 DOI: 10.1073/Pnas.212515299 |
0.69 |
|
| 2001 |
Zarutskie JA, Busch R, Zavala-Ruiz Z, Rushe M, Mellins ED, Stern LJ. The kinetic basis of peptide exchange catalysis by HLA-DM. Proceedings of the National Academy of Sciences of the United States of America. 98: 12450-5. PMID 11606721 DOI: 10.1073/Pnas.211439398 |
0.671 |
|
| 2000 |
Sato AK, Zarutskie JA, Rushe MM, Lomakin A, Natarajan SK, Sadegh-Nasseri S, Benedek GB, Stern LJ. Determinants of the peptide-induced conformational change in the human class II major histocompatibility complex protein HLA-DR1. The Journal of Biological Chemistry. 275: 2165-73. PMID 10636922 DOI: 10.1074/Jbc.275.3.2165 |
0.684 |
|
| 1999 |
Zarutskie JA, Sato AK, Rushe MM, Chan IC, Lomakin A, Benedek GB, Stern LJ. A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding. Biochemistry. 38: 5878-87. PMID 10231540 DOI: 10.1021/Bi983048M |
0.688 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2006 |
Silvian L, Jin P, Carmillo P, Boriack-Sjodin PA, Pelletier C, Rushe M, Gong B, Sah D, Pepinsky B, Rossomando A. Artemin crystal structure reveals insights into heparan sulfate binding. Biochemistry. 45: 6801-12. PMID 16734417 DOI: 10.1021/bi060035x |
0.274 |
|
| 2006 |
Reid C, Rushe M, Jarpe M, van Vlijmen H, Dolinski B, Qian F, Cachero TG, Cuervo H, Yanachkova M, Nwankwo C, Wang X, Etienne N, Garber E, Bailly V, de Fougerolles A, et al. Structure activity relationships of monocyte chemoattractant proteins in complex with a blocking antibody. Protein Engineering, Design & Selection : Peds. 19: 317-24. PMID 16682434 DOI: 10.1093/protein/gzl015 |
0.254 |
|
| 2006 |
Clark LA, Boriack-Sjodin PA, Eldredge J, Fitch C, Friedman B, Hanf KJ, Jarpe M, Liparoto SF, Li Y, Lugovskoy A, Miller S, Rushe M, Sherman W, Simon K, Van Vlijmen H. Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design. Protein Science : a Publication of the Protein Society. 15: 949-60. PMID 16597831 DOI: 10.1110/Ps.052030506 |
0.237 |
|
| 2020 |
Hanf KJM, Arndt JW, Liu Y, Gong BJ, Rushe M, Sopko R, Massol R, Smith B, Gao Y, Dalkilic-Liddle I, Lee X, Mojta S, Shao Z, Mi S, Pepinsky RB. Functional activity of anti-LINGO-1 antibody opicinumab requires target engagement at a secondary binding site. Mabs. 1713648. PMID 31928294 DOI: 10.1080/19420862.2020.1713648 |
0.205 |
|
| 2016 |
Marcotte D, Rushe M, Arduini R, Lukacs C, Atkins K, Sun X, Little K, Cullivan M, Murugan P, Patterson T, Hesson T, McKee T, May-Dracka T, Xin Z, Bertolotti-Ciarlet A, et al. Germinal-center Kinase-like Kinase (GLK) Co-crystal Structure Reveals a Swapped Activation Loop and C-terminal Extension. Protein Science : a Publication of the Protein Society. PMID 27727493 DOI: 10.1002/pro.3062 |
0.186 |
|
| 2019 |
Nguyen L, Montrasio F, Pattamatta A, Tusi SK, Bardhi O, Meyer KD, Hayes L, Nakamura K, Banez-Coronel M, Coyne A, Guo S, Laboissonniere LA, Gu Y, Narayanan S, Smith B, ... ... Rushe M, et al. Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model. Neuron. PMID 31831332 DOI: 10.1016/J.Neuron.2019.11.007 |
0.138 |
|
| 2008 |
Rushe M, Silvian L, Bixler S, Chen LL, Cheung A, Bowes S, Cuervo H, Berkowitz S, Zheng T, Guckian K, Pellegrini M, Lugovskoy A. Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site. Structure (London, England : 1993). 16: 798-808. PMID 18462684 DOI: 10.1016/J.Str.2008.02.012 |
0.136 |
|
| 2022 |
Jambeau M, Meyer KD, Hruska-Plochan M, Tabet R, Lee CZ, Ray-Soni A, Aguilar C, Savage K, Mishra N, Cavegn N, Borter P, Lin CC, Jansen-West KR, Jiang J, Freyermuth F, ... ... Rushe M, et al. Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of disease. Proceedings of the National Academy of Sciences of the United States of America. 119: e2123487119. PMID 36454749 DOI: 10.1073/pnas.2123487119 |
0.105 |
|
| 2018 |
May-Dracka TL, Arduini R, Bertolotti-Ciarlet A, Bhisetti G, Brickelmaier M, Cahir-McFarland E, Enyedy I, Fontenot JD, Hesson T, Little K, Lyssikatos J, Marcotte D, McKee T, Murugan P, Patterson T, ... ... Rushe M, et al. Investigating small molecules to inhibit germinal center kinase-like kinase (GLK/MAP4K3) upstream of PKCθ phosphorylation: Potential therapy to modulate T cell dependent immunity. Bioorganic & Medicinal Chemistry Letters. PMID 29636220 DOI: 10.1016/j.bmcl.2018.03.032 |
0.101 |
|
| 2019 |
Almeida S, Krishnan G, Rushe M, Gu Y, Kankel MW, Gao FB. Production of poly(GA) in C9ORF72 patient motor neurons derived from induced pluripotent stem cells. Acta Neuropathologica. PMID 31624870 DOI: 10.1007/S00401-019-02083-Z |
0.031 |
|
| 2017 |
Sopko R, Mugford JW, Lehmann A, Shapiro RI, Rushe M, Kulkarni A, Worrall J, Amatucci J, Wen D, Pederson NE, Minesinger BK, Arndt JW, Pepinsky B. Engineering potent long-acting variants of the Wnt inhibitor DKK2. Protein Engineering, Design & Selection : Peds. 1-14. PMID 28180900 DOI: 10.1093/protein/gzx007 |
0.028 |
|
| Hide low-probability matches. |